This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ashour, J. Articles by Hondalus, M. K. Search for Related Content PubMed PubMed Citation Articles by Ashour, J. Articles by Hondalus, M. K.

Phenotypic Mutants of the Intracellular Actinomycete Rhodococcus equi Created by In Vivo Himar1 Transposon Mutagenesis

Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115

Received 23 September 2002/ Accepted 8 January 2003

Rhodococcus equi is a facultative intracellular opportunistic pathogen of immunocompromised people and a major cause of pneumonia in young horses. An effective live attenuated vaccine would be extremely useful in the prevention of R. equi disease in horses. Toward that end, we have developed an efficient transposon mutagenesis system that makes use of a Himar1 minitransposon delivered by a conditionally replicating plasmid for construction of R. equi mutants. We show that Himar1 transposition in R. equi is random and needs no apparent consensus sequence beyond the required TA dinucleotide. The diversity of the transposon library was demonstrated by the ease with which we were able to screen for auxotrophs and mutants with pigmentation and capsular phenotypes. One of the pigmentation mutants contained an insertion in a gene encoding phytoene desaturase, an enzyme of carotenoid biosynthesis, the pathway necessary for production of the characteristic salmon color of R. equi. We identified an auxotrophic mutant with a transposon insertion in the gene encoding a putative dual-functioning GTP cyclohydrolase II-3,4-dihydroxy-2-butanone-4-phosphate synthase, an enzyme essential for riboflavin biosynthesis. This mutant cannot grow in minimal medium in the absence of riboflavin supplementation. Experimental murine infection studies showed that, in contrast to wild-type R. equi, the riboflavin-requiring mutant is attenuated because it is unable to replicate in vivo. The mutagenesis methodology we have developed will allow the characterization of R. equi virulence mechanisms and the creation of other attenuated strains with vaccine potential.

This article has been cited by other articles:

• Kristich, C. J., Nguyen, V. T., Le, T., Barnes, A. M. T., Grindle, S., Dunny, G. M. (2008). Development and Use of an Efficient System for Random mariner Transposon Mutagenesis To Identify Novel Genetic Determinants of Biofilm Formation in the Core Enterococcus faecalis Genome. Appl. Environ. Microbiol. 74: 3377-3386 [Abstract] [Full Text]  
• Maier, T. M., Pechous, R., Casey, M., Zahrt, T. C., Frank, D. W. (2006). In Vivo Himar1-Based Transposon Mutagenesis of Francisella tularensis.. Appl. Environ. Microbiol. 72: 1878-1885 [Abstract] [Full Text]  
• Stewart, P. E., Hoff, J., Fischer, E., Krum, J. G., Rosa, P. A. (2004). Genome-Wide Transposon Mutagenesis of Borrelia burgdorferi for Identification of Phenotypic Mutants. Appl. Environ. Microbiol. 70: 5973-5979 [Abstract] [Full Text]  
• Darrah, P. A., Monaco, M. C. G., Jain, S., Hondalus, M. K., Golenbock, D. T., Mosser, D. M. (2004). Innate Immune Responses to Rhodococcus equi. J. Immunol. 173: 1914-1924 [Abstract] [Full Text]